It seems that COVID-19 like vaccines you wait 8 months for one and then two come at the same time, just like waiting for a Bus.
This time we have another RNA vaccine abit like the other one. So this now gives people with MS two choices. This new one has the code mRNA-1273.
This give very similar results, in fact the results are nearerly identical to the study using BNT162b. In the mRNA-1273 study the results are also based on about 95/~30,0000 people infected with SARS-CoV-2 and the level of protection is over 90-95% and of the vaccinated people who got disease the symptoms were mild….This just what you want from a vaccine.
We have heard following Pres Trumpster’s first speech since losing that both these agents are likely to get approved by the FDA before Christmas
So the bar has been set for the others to equal or better. Anything below 90% protection will be seen as inferior to the RNA vaccines. In terms of anti-COVID levels the adenoviral vaccines may be abit lower, but the question is how long do the antibodies last. the company making RNA-1273 had people treated since March.
ProfG will be happy to know that they have an EBV specific vaccine mRNA-1195.
Big question which big Pharma is going to eat them up